Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Receivables: 2009-2019

Historic Receivables for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2019 value amounting to $10.1 million.

  • Avadel Pharmaceuticals' Receivables fell 55.03% to $7.3 million in Q2 2020 from the same period last year, while for Jun 2020 it was $40.7 million, marking a year-over-year decrease of 39.80%. This contributed to the annual value of $10.1 million for FY2019, which is 42.47% down from last year.
  • As of FY2019, Avadel Pharmaceuticals' Receivables stood at $10.1 million, which was down 42.47% from $17.6 million recorded in FY2018.
  • In the past 5 years, Avadel Pharmaceuticals' Receivables ranged from a high of $17.8 million in FY2016 and a low of $7.5 million during FY2015.
  • Its 3-year average for Receivables is $14.1 million, with a median of $14.8 million in 2017.
  • In the last 5 years, Avadel Pharmaceuticals' Receivables surged by 345.92% in 2015 and then slumped by 42.47% in 2019.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Receivables stood at $7.5 million in 2015, then spiked by 138.27% to $17.8 million in 2016, then decreased by 17.12% to $14.8 million in 2017, then grew by 18.78% to $17.6 million in 2018, then crashed by 42.47% to $10.1 million in 2019.